TRIM21 and systemic lupus erythematosus: In 2017, Gimenez-Romero et al. developed the first label-free multiplex piezoelectric biosensor for monitoring the anti-TRIM21 and anti-TROVE2 circulating autoantibodies, which are common autoantibodies that target autoantigens TRIM21 and TROVE2, for SLE diagnosis.